OSU pathology home page

Zaibo Li, MD, PhD, MBA

Professor-Clinical
Endowed University Pathology Service Professorship

Zaibo Li, MD, PhD

Phone:

614-366-4859

E-mail:

Email Dr. Li

Mailing Address:

E403 Doan Hall
410 W. 10th Ave
Columbus, OH 43210

Biosketch

Zaibo Li, MD, Ph.D, MBA is a Professor, Director of Cytopathology and Cytopathology Fellowship Program, Associate Director of Digital and Computational Pathology at The Ohio State University Wexner Medical Center. He also holds an Endowed University Pathology Services Anatomic Pathology Professorship.

Dr. Li is board certified in Anatomic/Clinical Pathology and Cytopathology. His practice and academic interests are breast pathology, gynecological pathology, cytopathology and digital pathology. Dr. Li received his MD from Peking University Health Science Center in Beijing, China and Ph.D and MBA from the University of Rochester in Rochester, NY. He completed his residency in Anatomic and Clinical Pathology and a fellowship in Cytopathology at the University of Pittsburgh Medical Center in Pittsburgh, PA, and then completed a second fellowship in Breast/Gynecologic Pathology at Magee-Womens Hospital of UPMC in Pittsburgh, PA.

Dr. Li has published more than 150 scientific articles and many book chapters. He is currently served as section or associate editor/editorial board for multiple scientific journals and also served on multiple national society committees. He has presented lectures on many national/international pathology conferences and teaching courses.

Board Certifications

2013 Cytopathology, American Board of Pathology

2012 Anatomic and Clinical Pathology, American Board of Pathology

Academic and Medical Appointments

2023-Present Professor, Department of Pathology, The Ohio State University, Columbus, OH

2019-2023 Associate Professor, Department of Pathology, The Ohio State University, Columbus, OH

2014-2019 Assistant Professor, Department of Pathology, The Ohio State University, Columbus, OH

Education and Training

2013-2014 Fellow, Breast and Gynecological Pathology, Magee Womens Hospital of Univ. of Pittsburgh Medical Center

2012-2013 Fellow, Cytopathology, University of Pittsburgh Medical Center, Pittsburgh, PA

2008-2012 Resident, Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA

Selected Publications

Search in PubMed

  • Satturwar S, Shaker N, Sinclair W, Shen R, Parwani AV, Ding Q, Li Z. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens. Cancer Cytopathol. 2023 May 17. doi: 10.1002/cncy.22708.
  • Challa B, Tahir M, Hu Y, Kellough D, Lujan G, Sun S, Parwani AV, Li Z. Artificial Intelligence-Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow. Mod Pathol. 2023 May 11:100216. doi: 10.1016/j.modpat.2023.100216.
  • Hou Y, Nitta H, Li Z. HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept. Cancers. 2023; 15(10):2664. https://doi.org/10.3390/cancers15102664
  • Lewis G, Fong N, Gjeorgjievski SG, Li XB, Li Z, Wei S, Sturgis CD, Wang C, Komforti M, Zhang H, Downs E, Cui X, McIntire P, Hoda RS, Rowe JJ, Sciallis A, Zhang G. Low-grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients. Histopathology. 2023 Apr 17. doi: 10.1111/his.14917.
  • Zhong F, Li Z, Sun Y, Xiao Y, Li J, Zhou X, Cong Q, Sui L, Tao X, Zhao C. HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China. Front Oncol. 2023 Mar 29;13:1161631. doi: 10.3389/fonc.2023.1161631.
  • Hu Y, Jones D, Zhao W, Tozbikian G, Wesolowski R, Parwani AV, Li Z. Incidence, Clinicopathologic Features, HER2 FISH Profile and Oncotype DX Results of HER2-low Breast Cancers: Experience from a Single Academic Center. Mod Pathol. 2023 Mar 24:100164. doi: 10.1016/j.modpat.2023.100164.
  • Shafi S, Nitta H, Shah M, Challa B, Parwani AV, Li Z. HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers. Am J Clin Pathol. 2023 Mar 1:aqac179. doi: 10.1093/ajcp/aqac179.
  • Khoury T, Rosa M, Nayak A, Karabakhtsian RG, Fadare O, Li Z, Turner BM, Fang YV, Kumarapeli A, Li X, Numbere N, Villatoro TM, Wang J, Sadeghi S, Attwood K, George A, Bhargava R. Clinicopathological Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-Institutional Study. Mod Path. Volume 36, Issue 2, February 2023, 100006.
  • Liu Y, Han D, Parwani AV, Li Z. Applications of Artificial Intelligence in Breast Pathology. Arch Pathol Lab Med. 2023 Feb 16. doi: 10.5858/arpa.2022-0457-RA.
  • Wu S, Yue M, Zhang J, Li X, Li Z, Zhang H, Wang X, Han X, Cai L, Shang J, Jia Z, Wang X, Li J, Liu Y. The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer. Mod Path. 2023 Jan 10;36(3):100054.
  • Shaker N, Chen W, Sinclair W, Parwani AV, Li Z. Identifying SOX17 as a sensitive and specific marker for ovarian and endometrial carcinomas. Mod Path. Volume 36, Issue 1, January 2023, 100038.
  • Huang Z, Shao W, Han Z, Alkashash AM, De la Sancha C, Parwani AV, Nitta H, Hou Y, Wang T, Salama P, Rizkalla M, Zhang J, Huang K, Li Z. Artificial intelligence reveals features associated with breast cancer neoadjuvant chemotherapy responses from multi-stain histopathologic images. NPJ Precis Oncol. 2023 Jan 27;7(1):14. doi: 10.1038/s41698-023-00352-5.
  • Shaker N, Shafi S, Parkinson B, Chen W, Parwani AV, Ding Q, Li Z. Wnt Family Member 9b (Wnt9b) is a Sensitive and Specific Marker for Triple Negative Breast Carcinoma Including Metaplastic Carcinoma. Am J Surg Pathol. 2023 Jan 1;47(1):47-54.
  • Amendoeira I, Arcidiacono P, Barizzi J, Capitanio A, Cuatrecasas M, Di Matteo F, Doglioni C, Fukushima N, Fulciniti F, Ginès A, Giovannini M, Li Z, Lopes J, Lujan G, Parisi A, Poizat F, Reggiani B, Stigliano S, Taffon C, Verri M, and Crescenzi A. New digital confocal laser microscopy may booster real-time evaluation of endoscopic ultrasound guided fine needle biopsy (EUS-FNB) from solid pancreatic lesions. Data from an international multicenter study. eBioMedicine. 2022 Dec;86:104377.
  • Patel A, Shaker N, Erck A, Kellough DA, Palermini E, Li Z, Lujan G, Satturwar S, Parwani AV. Types and frequency of whole slide imaging scan failures in a clinical high throughput digital pathology scanning laboratory. Journal of Pathology Informatics. Volume 13, 2022 Jun 29;13:100112.
  • Shafi S, Kellough DA, Lujan G, Satturwar S, Parwani AV, Li Z. Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use. Journal of Pathology Informatics. Volume 13, 2022 Jun 30;13:100122.
  • Shafi S, Hu Y, Parwani AV, Ding Q, Li Z. Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center. Breast Cancer Res Treat. 2022 Dec;196(3):463-469.
  • Li Z, Xu H, Fan F. Approach to Mediastinal Fine Needle Aspiration Cytology. Adv Anat Pathol. 2022 Nov 1;29(6):337-348.
  • Li H, Wang J, Li Z, Dababneh M, Wang F, Zhao P, Smith GH, Teodoro G, Li M, Kong J, Li X. Deep learning-based pathology image analysis enhances Magee feature correlation with Oncotype DX Breast Recurrence Score. Front Med (Lausanne). 2022 Jun 14;9:886763.
  • Hou Y, Peng Y, Li Z. Update on prognostic and predictive biomarkers of breast cancer. Semin Diagn Pathol. 2022 Sep;39(5):322-332.